An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Olanzapine (Primary) ; Valproate semisodium (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 29 May 2015 Status changed from completed to withdrawn prior to enrolment as per ClinicalTrials.gov record.
- 12 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.